Monopar Therapeutics Reports Third Quarter 2024 Financial Results and Recent Developments
Provided By GlobeNewswire
Last update: Nov 8, 2024
In-licensed ALXN-1840 (a Late-Stage Wilson Disease Drug Candidate) from Alexion, AstraZeneca Rare Disease
Two Novel Radiopharma Clinical Trials now Active and Enrolling Patients with Advanced Solid Cancers
